Elevated C-Reactive Protein as a Potential Biomarker for Neurological Adverse Events in Immune Checkpoint Inhibitor Therapy: A Prospective Cohort Study.

Saved in:
Bibliographic Details
Title: Elevated C-Reactive Protein as a Potential Biomarker for Neurological Adverse Events in Immune Checkpoint Inhibitor Therapy: A Prospective Cohort Study.
Authors: Duzzi L; Department of Neurology, Hannover Medical School, Hannover, Germany., Möhn N; Department of Neurology, Hannover Medical School, Hannover, Germany., Narten E; Department of Neurology, Hannover Medical School, Hannover, Germany., Thomas J; Department of Neurology, Hannover Medical School, Hannover, Germany., Mahjoub S; Department of Neurology, Hannover Medical School, Hannover, Germany., Grote-Levi L; Department of Neurology, Hannover Medical School, Hannover, Germany., Jendretzky K; Department of Neurology, Hannover Medical School, Hannover, Germany., Nay S; Department of Neurology, Hannover Medical School, Hannover, Germany., Konen F; Department of Neurology, Hannover Medical School, Hannover, Germany., Wiegmann J; Department of Haematology, Haemostaseology, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany., Beutel G; Department of Haematology, Haemostaseology, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany., Fröhlich T; Department of Haematology, Haemostaseology, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany., Bollmann BA; Department of Pneumology, Hannover Medical School, Hannover, Germany., Wirth T; Department of Gastroenterology, Hannover Medical School, Hannover, Germany., von Wasielewski I; Skin-Cancer-Center, Department of Dermatology, Allergology, and Venereology, Hannover Medical School, Carl-Neuberg-Str. 1, Hannover, Germany., Heidel FH; Department of Haematology, Haemostaseology, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany., Gutzmer R; Skin-Cancer-Center, Department of Dermatology, Allergology, and Venereology, Hannover Medical School, Carl-Neuberg-Str. 1, Hannover, Germany.; Department of Dermatology, Johannes Wesling Medical Center, Ruhr University Bochum, Minden, Germany., Skripuletz T; Department of Neurology, Hannover Medical School, Hannover, Germany., Ivanyi P; Department of Haematology, Haemostaseology, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
Corporate Authors: ICOG (Immune Cooperative Oncology Group)-Investigators
Source: Oncology research [Oncol Res] 2026 Apr 22; Vol. 34 (5), pp. 17. Date of Electronic Publication: 2026 Apr 22 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Tech Science Press Country of Publication: United States NLM ID: 9208097 Publication Model: eCollection Cited Medium: Internet ISSN: 1555-3906 (Electronic) Linking ISSN: 09650407 NLM ISO Abbreviation: Oncol Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1555-3906
DOI:10.32604/or.2026.074095